BIOA
BioAge Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.98
+0.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 68.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.73x
- Price / sales
- 26.50x
- Price / cash flow
- -3.13x
Enterprise value
- Enterprise value
- -$41.5M
- EV / sales
- -4.01x
- EV / EBITDA
- 0.44x
- EV / EBIT
- 0.39x
- Market cap
- $274.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026